Nucana plc
Patent Applications and Registrations
Patent applications and USPTO patent grants for Nucana plc.The latest application filed is for "2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds".
Company Profile
28.35.34
Trademarks
- Nucana plc - Edinburgh GB
- NuCana plc - Edinburg GB
- NuCana PLC - London GB
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| 2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds App 20220306675 - Griffith; Hugh ; et al. | 2022-09-29 |
| Floxuridine synthesis Grant 11,414,451 - Kotala , et al. August 16, 2 | 2022-08-16 |
| Synthesis of phosphate derivatives Grant 11,414,452 - Griffith , et al. August 16, 2 | 2022-08-16 |
| Cancer treatments Grant 11,400,107 - Griffith , et al. August 2, 2 | 2022-08-02 |
| Crystalline form of gemcitabine Grant 11,377,467 - Griffith July 5, 2 | 2022-07-05 |
| 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds Grant 11,352,387 - Griffith , et al. June 7, 2 | 2022-06-07 |
| Formulation Comprising A Gemcitabine-prodrug App 20220031727 - Griffith; Hugh ; et al. | 2022-02-03 |
| Process For Preparing Nucleoside Prodrugs App 20220033433 - McGuigan (Deceased); Christopher ; et al. | 2022-02-03 |
| Formulations Of Phosphoramidate Derivatives Of Nucleoside Drugs App 20220031728 - Kennovin; Gordon ; et al. | 2022-02-03 |
| Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20220023330 - McGuigan; Christopher ; et al. | 2022-01-27 |
| Salt Of Triphosphate Phosphoramidates Of Nucleotides As Anticancer Compounds App 20220024963 - Griffith; Hugh ; et al. | 2022-01-27 |
| Crystalline Form Of Gemcitabine App 20210188893 - Griffith; Hugh | 2021-06-24 |
| Formulation comprising a gemcitabine-prodrug Grant 11,040,051 - Griffith , et al. June 22, 2 | 2021-06-22 |
| Process for preparing nucleoside prodrugs Grant 11,040,997 - McGuigan , et al. June 22, 2 | 2021-06-22 |
| Salts Of Diphosphate Phosphoramidate Of Nucleosides As Anticancer Compounds App 20210171566 - Griffith; Hugh ; et al. | 2021-06-10 |
| Phosphoramidate Nucleoside Derivatives As Anticancer Agents App 20210130387 - Griffith; Hugh ; et al. | 2021-05-06 |
| Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 10,993,957 - McGuigan , et al. May 4, 2 | 2021-05-04 |
| Cancer Treatments Based On Gemcitabine Prodrugs App 20210100825 - Griffith; Hugh ; et al. | 2021-04-08 |
| Phosphoramidate nucleoside derivatives as anticancer agents Grant 10,906,929 - Griffith , et al. February 2, 2 | 2021-02-02 |
| Diastereoselective Synthesis Of Phosphate Derivatives App 20210009625 - Kotala; Mani Bushan ; et al. | 2021-01-14 |
| Formulation Comprising A Gemcitabine-prodrug App 20200397810 - Griffith; Hugh ; et al. | 2020-12-24 |
| Treatment Regimens App 20200345755 - Griffith; Hugh | 2020-11-05 |
| Formulation comprising a gemcitabine-prodrug Grant 10,786,523 - Griffith , et al. September 29, 2 | 2020-09-29 |
| Diastereoselective synthesis of phosphate derivatives Grant 10,774,104 - Kotala , et al. Sept | 2020-09-15 |
| Combination Therapy For Cancer App 20200268783 - Griffith; Hugh | 2020-08-27 |
| Floxuridine Synthesis App 20200262859 - Kotala; Mani B. ; et al. | 2020-08-20 |
| Gemcitabine Prodrugs App 20200262861 - Griffith; Hugh ; et al. | 2020-08-20 |
| Combination Therapy App 20200197430 - Griffith; Hugh | 2020-06-25 |
| 2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds App 20200181189 - Griffith; Hugh ; et al. | 2020-06-11 |
| Synthesis Of 3'-deoxyadenosine-5'-o-[phenyl(benzyloxy-l-alaninyl)]phosphate (nuc-7738) App 20200181190 - Dammalapati; Venkata Lakshmi Narasimha Rao ; et al. | 2020-06-11 |
| Synthesis Of Phosphate Derivatives App 20200181186 - Griffith; Hugh ; et al. | 2020-06-11 |
| Methods of separating gemcitabine-phosphate diastereoisomers Grant 10,669,300 - Griffith | 2020-06-02 |
| Combination therapy for cancer Grant 10,660,912 - Griffith | 2020-05-26 |
| Gemcitabine prodrugs Grant 10,662,213 - Griffith , et al. | 2020-05-26 |
| 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti- cancer compounds Grant 10,570,168 - Griffith , et al. Feb | 2020-02-25 |
| Phosphoramidate Nucleoside Derivatives As Anticancer Agents App 20190375779 - Griffith; Hugh | 2019-12-12 |
| Adenosine Derivatives For Use In The Treatment Of Cancer App 20190375778 - Griffith; Hugh ; et al. | 2019-12-12 |
| Cancer Treatments App 20190374564 - Griffith; Hugh ; et al. | 2019-12-12 |
| Phosphoramidate compounds and methods of use Grant RE47,589 - McGuigan Sep | 2019-09-03 |
| Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer App 20190201432 - McGuigan; Christopher ; et al. | 2019-07-04 |
| Formulation Comprising A Gemcitabine-prodrug App 20190022118 - Griffith; Hugh ; et al. | 2019-01-24 |
| Combination Therapy App 20190022117 - Griffith; Hugh | 2019-01-24 |
| Formulations Of Phosphoramidate Derivatives Of Nucleoside Drugs App 20180369266 - Kennovin; Gordon ; et al. | 2018-12-27 |
| Diastereoselective Synthesis Of Phosphate Derivatives App 20180362571 - Kotala; Mani B. ; et al. | 2018-12-20 |
| Formulation comprising a gemcitabine-prodrug Grant 10,117,888 - Griffith , et al. November 6, 2 | 2018-11-06 |
| Cancer Treatments Based On Gemcitabine Prodrugs App 20180289733 - Griffith; Hugh ; et al. | 2018-10-11 |
| Combination Therapy For Cancer App 20180271889 - Griffith; Hugh | 2018-09-27 |
| Process For Preparing Nucleoside Prodrugs App 20180273575 - McGuigan; Christopher ; et al. | 2018-09-27 |
| Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Grant 10,022,390 - McGuigan , et al. July 17, 2 | 2018-07-17 |
Company Registrations
| SEC | 0001709626 | NuCana plc of UNITED KINGDOM |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 